Pear Therapeutics, Inc. is a commercial-stage healthcare company pioneering a new class of software-based medicines, sometimes referred to as Prescription Digital Therapeutics (PDT), which use software to treat diseases directly. The firm aims to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. It has a pipeline of products and product candidates across therapeutic areas, including the first three PDTs with disease treatment claims from the FDA. The company’s lead product, reSET, for the treatment of substance use disorder, was the first PDT to receive marketing authorization from the FDA to treat disease. Its second product, reSET-O, for the treatment of opioid use disorder, was the first PDT to receive Breakthrough Designation. Pear's third product, Somryst for the treatment of chronic insomnia, was the first PDT submitted through the FDA's traditional 510(k) pathway while simultaneously reviewed through the FDA's Software Precertification Pilot Program. The company was founded on December 1, 2020 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Pear Therapeutics Inc - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Pear Therapeutics Inc - Ordinary Shares - Class A market cap is $100.00.
What is the 52-week high for Pear Therapeutics Inc - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Pear Therapeutics Inc - Ordinary Shares - Class A 52 week high is $0.0197 as of April 25, 2024.
What is the 52-week low for Pear Therapeutics Inc - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Pear Therapeutics Inc - Ordinary Shares - Class A 52 week low is $0.00 as of April 25, 2024.
What was Pear Therapeutics Inc - Ordinary Shares - Class A stock price yesterday?
Pear Therapeutics Inc - Ordinary Shares - Class A stock price yesterday was $0.0001.
What is the 50-day moving average of Pear Therapeutics Inc - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Pear Therapeutics Inc - Ordinary Shares - Class A 50-day moving average is $0.00.